Logsdon R G, Teri L, Williams D E, Vitiello M V, Prinz P N
University of Washington Health Sciences Center.
J Clin Exp Neuropsychol. 1989 Dec;11(6):892-8. doi: 10.1080/01688638908400942.
A diagnostic index, based on WAIS-R subtests, to identify patients with Dementia of the Alzheimer Type (DAT) and differentiate them from normal or depressed elderly was investigated. In a sample of 82 geriatric outpatient clinic patients who complained of memory loss, 22% of patients with probable DAT and 13% of nondemented patients obtained a positive profile. The occurrence of the profile in the two groups was not significantly different, nor were differences in education or severity of dementia found between subjects who did or did not obtain the profile. In a second sample of 173 elderly research volunteers, the profile occurred in 7% of DAT subjects, 10% of subjects complaining of memory loss who did not meet diagnostic criteria for DAT, 7% of nondemented major depressed subjects, and 7% of normal control subjects. Thus, the current investigation did not find the profile useful in differentiating DAT from other common disorders among elderly subjects. The authors conclude that a more comprehensive test battery remains the diagnostic tool of choice for differentiating DAT from other disorders.
研究了一种基于韦氏成人智力量表修订版(WAIS-R)子测验的诊断指标,以识别阿尔茨海默型痴呆(DAT)患者,并将他们与正常或抑郁的老年人区分开来。在82名主诉记忆丧失的老年门诊患者样本中,22%的可能患有DAT的患者和13%的非痴呆患者获得了阳性结果。两组中该结果的发生率没有显著差异,获得或未获得该结果的受试者在教育程度或痴呆严重程度上也没有差异。在173名老年研究志愿者的第二个样本中,该结果出现在7%的DAT受试者、10%主诉记忆丧失但不符合DAT诊断标准的受试者、7%的非痴呆重度抑郁受试者和7%的正常对照受试者中。因此,目前的研究未发现该结果有助于在老年受试者中将DAT与其他常见疾病区分开来。作者得出结论,更全面的测试组合仍然是将DAT与其他疾病区分开来的首选诊断工具。